Durability of the neutralizing antibody response to vaccine and non-vaccine HPV types 7 years following immunization with either Cervarix® or Gardasil® vaccine. [electronic resource]
Producer: 20200916Description: 2455-2462 p. digitalISSN:- 1873-2518
- Adolescent
- Antibodies, Neutralizing -- blood
- Antibodies, Viral -- blood
- Cross Protection
- Female
- Genotype
- Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 -- administration & dosage
- Humans
- Papillomaviridae -- classification
- Papillomavirus Infections -- immunology
- Papillomavirus Vaccines -- administration & dosage
- Time Factors
No physical items for this record
Publication Type: Clinical Trial, Phase IV; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.